SETDB1 and melanoma: SETDB1 has been found to be highly amplified in tumors of melanoma patients and melanoma cell lines, with overexpression contributing to a more aggressive phenotype in vivo and in vitro studies by upregulating thrombospondin 1 (THBS1) expression in a H3K4me1-dependent manner [100].